key: cord-0257522-9i2iqryi authors: Sarma, A.; Christenson, S. A.; Zha, B. S.; Pisco, A. O.; Neyton, L. P. A.; Mick, E.; Sinha, P.; Wilson, J. G.; Moazed, F.; Leligdowicz, A.; Maddali, M. V.; Siegel, E. R.; Lyon, Z.; Zhou, H.; Jauregui, A.; Ghale, R.; Caldera, S.; Serpa, P. H.; Deiss, T.; Love, C.; Byrne, A.; Kalantar, K. L.; DeRisi, J. L.; Erle, D. J.; Krummel, M. F.; Kangelaris, K. N.; Hendrickson, C. M.; Woodruff, P. G.; Matthay, M. A.; COMET Consortium,; Langelier, C. R.; Calfee, C. S. title: Hyperinflammatory ARDS is characterized by interferon-stimulated gene expression, T-cell activation, and an altered metatranscriptome in tracheal aspirates date: 2022-04-05 journal: nan DOI: 10.1101/2022.03.31.22272425 sha: 6662b4198485f432332b20c485eec8ab29dc80b9 doc_id: 257522 cord_uid: 9i2iqryi Two molecular phenotypes of the acute respiratory distress syndrome (ARDS) with substantially different clinical trajectories have been identified. Classification as "hyperinflammatory" or "hypoinflammatory" depends on systemic biomarker profiling. Differences in the biology underlying these phenotypes at the site of injury, the lung, are unknown. We analyze tracheal aspirate transcriptomes from 46 mechanically ventilated subjects to assess differences in lung inflammation and repair between ARDS phenotypes. We then integrate these results with metatranscriptomic sequencing, single cell RNA sequencing, and plasma proteomics to identify distinct features of each ARDS phenotype. We also compare phenotype-specific differences in gene expression to experimental models of acute lung injury and use an in silico analysis to identify candidate treatments for each phenotype. We find that hyperinflammatory ARDS is associated with increased integrated stress response and interferon gamma signaling, distinct immune cell polarization, and differences in microbial community composition in TA. These findings demonstrate that each phenotype has distinct respiratory tract biology that may be relevant to developing effective therapies for ARDS. The acute respiratory distress syndrome (ARDS) is a clinical condition characterized by 96 noncardiogenic pulmonary edema and hypoxemia within one week of a physiologic insult 1 participants. In addition, we had TA sequencing from five participants who were intubated for 143 neurologic injury, had no evidence of pulmonary disease on chest x-ray (CXR), and were not 144 immunosuppressed. We used a previously validated three-variable classifier model to determine 145 ARDS molecular phenotype based on plasma IL-8, bicarbonate, and Protein C levels 14 . When 146 plasma biomarkers were unavailable from the day of TA collection (n=5), we used a recently 147 described and validated machine learning model to assign phenotype 11, 15 . 10 out of 41 ARDS 148 subjects (24%) had hyperinflammatory ARDS, which is consistent with the proportion of 149 hyperinflammatory subjects observed in previous studies 5-9 . There were four extrapulmonary 150 fungal infections (two C. albicans, one C. glabrata, and one H. capsulatum) in the 151 hyperinflammatory phenotype vs. zero in the hypoinflammatory phenotype (p < 0.01, Table 1 ). There were no significant differences in patient age, sex, BMI, immunosuppression, or ARDS Together, these analyses identify several novel pathways that are differentially regulated 183 between ARDS molecular phenotypes and support the hypothesis that previously described To further understand how pathways in each phenotype were dysregulated compared to 187 mechanically ventilated lungs, we next performed differential expression and pathway analyses 188 comparing each phenotype to five mechanically ventilated control samples ( Figure 1B and 1C, Supplementary Data 1C and 1D). 2,989 genes (15% of protein-coding genes) were differentially 190 expressed between hyperinflammatory ARDS participants and controls, while 2,132 genes 191 (11% of all protein-coding genes) were differentially expressed between hypoinflammatory 192 ARDS and controls. Notably, this analysis identified several cytokines that were activated in 193 both hyperinflammatory ARDS and hypoinflammatory ARDS compared to controls, including 194 IL1B, TNF, and IFNG. While this analysis identified some similarities between phenotypes, we 195 also identified several upstream regulators that were only significantly upregulated in 196 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. Expression Omnibus. We also identified 17 more datasets from other experimental models of 214 ARDS including ventilator-induced lung injury (VILI), ozone, hyperoxia, Pam3Cys (a TLR2 215 agonist), and hemorrhagic shock (Supplementary Data 3A). We used GEO2Enrichr 27 to identify 216 gene sets that were differentially expressed in lung injury compared to controls in experimental 217 models. We then used gsva to calculate a expression score for each of these gene sets in TA 218 samples and used limma to compare expression of these gene sets in each ARDS phenotype to 219 controls ( Figure 1D , Supplementary Data 3B and 3C). Gene sets from four models were 220 significantly enriched (FDR < 0.1) in TA from both ARDS phenotypes. As expected, LPS models 221 had a significant overlap with both phenotypes, but LPS experimental gene sets had higher 222 GSVA scores in hyperinflammatory participants. In addition, gene sets from five experimental 223 models (two ozone models, two LPS models, and one VILI model) were enriched in 224 hyperinflammatory ARDS, but were not enriched in hypoinflammatory ARDS, suggesting these 225 models better replicate dysregulated gene expression observed in the hyperinflammatory 226 phenotype. 228 229 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. To identify the sources of differential gene expression identified in bulk RNA sequencing 246 data, we used a neutrophil-preserving single-cell RNA sequencing (scSeq) pipeline to study TA 247 from eight COVID-negative patients with ARDS enrolled in a separate prospective, 248 observational cohort, the COVID-19 Multiphenotyping for Effective Therapies (COMET) study. TA scSeq was available from six participants with hypoinflammatory ARDS and two participants 250 with hyperinflammatory ARDS. 18,717 cells passed quality control filters (3,782 from 251 hyperinflammatory ARDS, Figure 2A ). We determined cell identities using SingleR 29 to compare 252 cell transcriptomes to signatures derived from the Human Primary Cell Atlas ( Figure 2B ). Neutrophils were the most common cell type identified in TA from both phenotypes (48% of 254 hyperinflammatory TA cells and 36% of hypoinflammatory TA cells, Figure 2C ), which 255 highlighted the importance of using neutrophil-preserving methods to study ARDS phenotypes. To identify cell-specific differences between ARDS phenotypes, we used MAST to fit 257 mixed effects models of differential gene expression (FDR < 0.1) 30 . To address We used connectome 38 , which compares single-cell gene expression to the FANTOM5 296 ligand-receptor database 39 , to identify ligand-receptor pairs in lower respiratory cells that were 297 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Plasma concentrations of 28 proteins were higher in hyperinflammatory ARDS than in 315 hypoinflammatory ARDS (FDR < 0.1, Figure 3A ). Some of these biomarkers confirmed known 316 differences between phenotypes, including higher concentrations of IL6 and TNF in 317 hyperinflammatory ARDS. In addition, we identified nine plasma protein biomarkers notably 318 higher in hyperinflammatory ARDS over controls ( Figure (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.03.31.22272425 doi: medRxiv preprint Phenotypes were associated with differences in the respiratory microbiome 332 Because our analyses demonstrated significant differences in host respiratory tract 333 biology in each phenotype, we hypothesized that each phenotype would have a distinct 334 respiratory microbiome that could stimulate a dysregulated response. We used a previously 335 described metagenomic sequencing pipeline to align non-human sequences in TA sequencing 336 to microbial genomes 43 and used established methods to filter background contamination from 337 samples 44 . Taxa were aggregated at the genus level for downstream analyses. There was no 338 significant difference in alpha diversity between phenotypes for all microbial taxa, bacteria, or 339 fungi ( Figure 4A ). There was a significant difference in microbial community composition 340 between phenotypes (Bray-Curtis distance, PERMANOVA p = 0.001, Figure 4B ). This 341 difference was not significant when the analysis was restricted to bacterial taxa (p = 0.117, 342 Figure 4C ), but was significant when the analysis was restricted to fungal taxa (p = 0.004, 343 Figure 4D ). We next compared differential abundance of microbial transcripts using 344 metagenomeSeq 45 . We found increased abundance of Candida in TA from patients with 345 hyperinflammatory ARDS ( Figure 4E ). In addition, we observed greater abundance of multiple 346 bacterial taxa in the hypoinflammatory phenotype, including Escherichia, Proteus, and 347 Citrobacter, three taxa in the Enterobactericeae family, which was associated with an increased 348 risk of ARDS in a cohort of trauma patients 46 . Together, these observations support the 349 hypothesis that there is a significant difference in microbial community composition between 350 ARDS phenotypes. In this study, we performed an integrated transcriptomic and proteomic analysis of 354 ARDS phenotypes. To our knowledge, this represents the first demonstration of differences in 355 pulmonary biology between molecular phenotypes of ARDS, which have previously been 356 characterized primarily using plasma biomarkers. We identified differences between phenotypes 357 in bulk RNA transcriptomes and used scSeq to identify distinctly polarized immune cells in the 358 TA. In addition, O-Link proteomics identified differences in plasma protein concentrations 359 consistent with these observations. We also found significant differences in the TA microbial 360 community composition between phenotypes. Our findings support the hypothesis that each 361 ARDS phenotype has distinct pulmonary pathobiology and may be more likely to respond to 362 treatments specifically targeting these dysregulated pathways. Here, we find hyperinflammatory ARDS was associated with markedly higher IFNγ 364 stimulated gene expression and T cell activation in TA. In bulk RNA sequencing, pathway 365 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.03.31.22272425 doi: medRxiv preprint analysis identified markedly higher expression of IFNγ stimulated genes and increased expression of genes stimulated by the T cell receptor. Plasma proteomics identified increased 367 concentrations of the IFNγ-stimulated proteins CXCL9 and CXCL10 and the T cell activation 368 marker CD5 in hyperinflammatory ARDS but not in hypoinflammatory ARDS. Notably, in an 369 alternative molecular phenotyping approach that used k-means clustering of plasma biomarkers 370 to categorize ARDS subjects into two molecular phenotypes ("reactive" and "uninflamed"), plasma IFNγ is one of the defining biomarkers of the higher mortality "reactive" phenotype 47 . Together, our analyses support a central role of IFNγ and T cell activation in hyperinflammatory 373 ARDS. We used scSeq to identify cell-specific differences in immune responses. We found 375 evidence of increased neutrophil migration and differentiation in hyperinflammatory ARDS. The interplay of the respiratory microbiome, lung injury, and ARDS has long been 386 hypothesized but remains an important knowledge gap in the field. In one experimental study, 387 changes in the respiratory microbiome mediated lung injury 50 , however, a small prior study 388 using 16S sequencing of mini-BAL specimens found no difference in the microbiome 389 composition between phenotypes 51 . Because we used metatransciptomic sequencing, we were 390 able to identify non-bacterial taxa present in TA samples. We identified significant differences in (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This analysis also has some limitations. The sample size for each analysis is modest; 432 however, it was adequately powered to detect large changes in gene expression and protein 433 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 448 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. In this analysis, we included all available subjects in each cohort who were: 1) admitted 760 to the intensive care unit for mechanical ventilation for ARDS or airway protection without 761 radiographic evidence of underlying pulmonary disease and 2) for whom we had TA sequencing 762 with at least 500,000 protein-coding counts. We reviewed PCA plots, hierarchical clustering, and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. We used estimate_richness to calculate the Shannon diversity index for all microbial 875 taxa, as well as subgroup analyses of bacterial and fungal genera, in TA samples. We then 876 used vegan 66 to estimate the Bray-Curtis dissimilarity between samples and used adonis2 to 877 calculate PERMANOVA p-values. We then used metagenomeSeq 45 to estimate differential 878 abundance between phenotypes using zero-inflated log-normal mixture models for each genus. Normalization factors were calculated using Wrench normalization and differential abundance 880 was estimated using fitFeatureModel. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.03.31.22272425 doi: medRxiv preprint Acute respiratory distress syndrome Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a 591 randomised, controlled, open-label, platform trial Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill 620 Patients With COVID-19 With Hyperinflammatory Phenotype Development and validation of parsimonious algorithms to classify acute 622 respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled 623 trials Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data Transcriptional regulation of macrophage polarization: enabling 673 diversity with identity Nuclear factor E2-related factor-2 (Nrf2) 675 is required for NLRP3 and AIM2 inflammasome activation Connectome: computation and visualization of cell-cell signaling 678 topologies in single-cell systems data A draft network of ligand-receptor-mediated multicellular signalling in human A Novel FADD-Homologous ICE/CED-3-like Protease, Is Recruited to 684 the CD95 (Fas/APO-1) Death-Inducing Signaling Complex The CXC chemokines IP-10 and Mig are necessary for IL-12-686 mediated regression of the mouse RENCA tumor IDseq-An open source cloud-based pipeline and analysis service for 690 metagenomic pathogen detection and monitoring Upper airway gene expression reveals suppressed immune responses to 692 SARS-CoV-2 compared with other respiratory viruses Differential abundance analysis for 694 microbial marker-gene surveys Lung Microbiota Is Related to Smoking Status and to Development of 696 Acute Respiratory Distress Syndrome in Critically Ill Trauma Patients Identification and validation of distinct biological phenotypes in patients 699 with acute respiratory distress syndrome by cluster analysis Alveolar Macrophage Transcriptional Programs Are Associated with 701 Outcomes in Acute Respiratory Distress Syndrome Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients Lung and gut microbiota are altered by hyperoxia and contribute to 706 oxygen-induced lung injury in mice Biological subphenotypes of acute respiratory distress syndrome may 708 not reflect differences in alveolar inflammation Diversity of the lung mycobiome is associated with severity of disease in 710 acute respiratory distress syndrome Microbial signatures in the lower airways of mechanically ventilated 712 COVID-19 patients associated with poor clinical outcome Enrichment of the lung microbiome with gut bacteria in sepsis and the 715 acute respiratory distress syndrome Some like it hot: Candida 717 activation of inflammasomes Gene Expression Analysis to Assess the 719 Relevance of Rodent Models to Human Lung Injury Modulation of Lipopolysaccharide-Induced Gene Transcription and 722 Promotion of Lung Injury by Mechanical Ventilation Conductive airway surfactant: surface-tension function, biochemical 725 composition, and possible alveolar origin Metagenomic comparison of tracheal aspirate and mini-bronchial 727 alveolar lavage for assessment of respiratory microbiota Integrating host response and unbiased microbe detection for lower 730 respiratory tract infection diagnosis in critically ill adults Acute respiratory distress syndrome: the Berlin definition CDC/NHSN surveillance definition of health care-735 associated infection and criteria for specific types of infections in the acute care setting Impaired immune signaling and changes in the lung microbiome precede 738 secondary bacterial pneumonia in COVID-19 taxize: taxonomic search and retrieval in R phyloseq: an R package for reproducible interactive analysis 742 and graphics of microbiome census data (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.03.31.22272425 doi: medRxiv preprint